IGF-1LR3 IG1 1mg*10vials

IGF-1 LR3 IG1 1mg*10 vials is an ultra-high concentration, high-quality, long-acting recombinant IGF-1 analog research peptide, a highly efficient upgraded flagship version of the standard IG01 specification. It retains the classic optimized long-acting R3-modified molecular structure and features 13 N-terminal amino acid extensions and site-specific amino acid substitutions, achieving an ultra-long half-life and complete resistance to IGFBP-mediated inactivation. Compared to the traditional 0.1mg specification, the concentration per vial of IG1 is increased tenfold, achieving saturated binding to the target and complete activation of the PI3K/Akt/mTOR signaling pathway, completely breaking through the efficacy ceiling of standard low-dose IGF-1 LR3 products. This product overcomes the limitations of growth hormone-dependent endogenous regulation, employing an ultra-concentrated formula specifically tailored for high-intensity cell remodeling research, high-load tissue repair modeling, extreme metabolic intervention, and validation of high-threshold peptide synergistic effects. It is a top-tier, highly efficient core research material for preclinical studies of advanced cell proliferation, bone metabolism, insulin resistance reversal, and deep anti-aging mechanisms.

Product Functions and Research Value

In cutting-edge, high-intensity laboratory studies, IGF-1 LR3 IG1 can fully saturate downstream core signaling pathways, triggering extreme activation of somatic cell proliferation, high-density lean tissue anabolism, glucose metabolic remodeling, and anti-apoptotic protection. Compared to traditional low-dose IG01, 1 mg IG1 provides 10 times the intensity of intervention, faster phenotypic response, and more durable metabolic regulation. Its core upgraded research value focuses on five high-threshold dimensions: First, it powerfully promotes myocyte proliferation and repair of severe myofiber damage, supporting high-load lean tissue proliferation models; second, it optimizes peripheral insulin signal sensitivity, achieving fundamental intervention in metabolic models of severe refractory insulin resistance; third, it strongly inhibits cellular oxidative stress and deep aging, significantly delaying the degenerative aging process in multiple tissues; fourth, it efficiently promotes osteoblast proliferation and bone mineralization, supporting high-standard bone metabolism and growth regulation research; fifth, it synergistically interacts with H-series growth hormone peptides with ultra-high amplitude to construct an ultra-efficient growth hormone/insulin-like growth factor-1 axis positive feedback loop, maximizing the efficacy of systemic anabolic metabolism and metabolic remodeling. The 1mg supersaturated high-activity specification exhibits significant experimental differentiation and ultra-stable long-term efficacy, perfectly suited for high-dose gradient threshold screening, extreme physiological intervention models, and research on highly complex compound peptides, providing saturated, highly discriminative, and authoritative data for exploring advanced pharmacology and cell biology mechanisms.

Core Product Advantages

1. Classic LR3 Long-Acting Ultra-Stable Structure: Inheriting mature Long R3 molecular optimization technology, it effectively resists the binding and inactivation of endogenous IGFBP1/IGFBP3 proteins. It maintains long-term free biological activity both in vitro and in vivo, with an ultra-long half-life, completely solving the defects of short half-life and rapid decay of natural IGF-1.

2. 1mg Ultra-High Concentration Upgraded Flagship Specification: The concentration is 10 times that of the standard 0.1mg product, achieving complete pathway saturation activation and extreme intervention intensity. It fills the research gap of insufficient efficacy of low-dose specifications in high-threshold extreme modeling scenarios.

3. Independent Direct High-Amplitude Pathway Activation: Completely independent of pituitary growth hormone secretion function, it directly supplements highly active IGF-1, rapidly triggering downstream anabolic metabolism, glucose metabolism, and cell survival pathways. It avoids the indirect efficacy lag in growth hormone monotherapy studies, achieving ultra-efficient physiological remodeling. 4. Ultra-high purity activity-locking process: Utilizing upgraded multi-stage gradient purification and full-vacuum freeze-drying technology, 100% peptide activity is preserved, with zero foreign protein interference. Experimental variables are ultrapure, ensuring the accuracy and reproducibility of conclusions from high-end, extreme research.

5. Advanced aseptic integrated packaging: High-standard aseptic packaging of 10 vials per pack. Each batch undergoes rigorous full-range HPLC purity testing and comes with complete official COA laboratory certification. Long-term stable activity maintenance makes it perfectly suited for cutting-edge research, key scientific research projects, and high-end global bulk custom procurement.